Histamine Receptors

Impromidine is a selective agonist of the histamine H2 receptor, effectively stimulating gastric mucosal blood flow and promoting acid secretion. Its potent activity makes it a valuable tool in studies investigating gastric physiology and the mechanisms underlying acid secretion. Impromidine can be utilized in research related to gastrointestinal disorders and the effects of histamine receptor modulation on gastric function.

(R)-(+)-Mequitazine is a histamine H1 receptor antagonist that inhibits histamine activity by competitively binding to H1 receptors in gastrointestinal, vascular, and respiratory tissues. This compound undergoes biotransformation in human liver microsomes, producing hydroxylated and S-oxidized metabolites. Additionally, (R)-(+)-Mequitazine has been shown to inhibit CYP3A-catalyzed midazolam 1'-hydroxylase activity. Its properties make it a valuable reagent for investigating various allergic diseases and related pharmacological studies.

D18024 is a potent histamine receptor inhibitor that demonstrates antiallergic and antihistaminic properties. This compound exhibits significant activity in modulating histamine-mediated processes, making it useful for research focused on allergy and inflammation pathways. D18024 can be employed in studies investigating the role of histamine receptors in various biological systems, contributing to the understanding of allergic responses and potential therapeutic interventions.

Minocromil is a histamine receptor antagonist primarily employed in the treatment of asthma. It functions by inhibiting the histamine H1 receptor, leading to the reduction of bronchoconstriction and inflammation. This compound is valuable in research related to allergic responses and the development of therapeutic strategies for asthma management.

CI-949 is a potent histamine receptor inhibitor known for its ability to suppress the release of key allergic mediators. It demonstrates inhibition of histamine, leukotriene C4/D4, and thromboxane B2 with IC50 values of 11.4 μM, 0.5 μM, and 0.1 μM, respectively. This compound is useful for studies focused on allergic reactions and inflammation, providing insights into therapeutic strategies for allergic conditions.

KP136 is a potent histamine receptor inhibitor that exhibits antiallergic properties. It effectively blocks histamine release with an IC50 of 76.1 μg/mL and degranulation at 63 μg/mL. This compound is valuable for research applications focusing on allergic responses and related inflammation processes.

FRG8701 is a selective antagonist of the Histamine H2 receptor, demonstrating an IC50 range of 0.25 to 0.43 μM. This compound exhibits significant inhibitory activity, making it a valuable tool for investigating histamine signaling pathways and their implications in various physiological processes. Research applications include studies on gastric acid secretion, allergic reactions, and potential therapeutic interventions for related pathologies.

H3 receptor-MO-1 is a selective modulator of the histamine H3 receptor, functioning as an antagonist to enhance release of neurotransmitters. This compound is pivotal for research into neurological disorders and sleep regulation, making it a valuable tool in studying the role of histamine in the central nervous system. Its unique pharmacological profile enables investigation into potential therapeutic applications for conditions such as cognitive deficits and mood disorders.

Histamine Receptors Inhibitor 1 (compound 303) functions as an inhibitor of H1 and H4 histamine receptors. This compound demonstrates key biological activity in modulating inflammatory processes and is particularly relevant for research applications focusing on autoimmune, allergic, and ocular conditions. Its ability to selectively inhibit these receptors makes it a valuable tool for investigating histamine-mediated pathways in various biological contexts.

Terfenadine N-oxide is a histamine H1 receptor antagonist with an IC50 value of 2.73 μM, also exhibiting inhibition of the hERG potassium channel with an IC50 of 0.698 μM. This compound is valuable for investigating histamine-related allergic diseases and the role of hERG channels in arrhythmias. Its dual activity makes it a useful tool for research in pharmacology and toxicology related to allergic responses and cardiac rhythm disturbances.

1-Methylhistamine dihydrochloride is a metabolite of histamine that primarily targets histamine receptors. This compound exhibits significant biological activity in the modulation of allergic responses and neurotransmission processes. It is widely utilized in research applications focusing on histamine signaling pathways and its role in various physiological and pathological conditions.

Histamine N-methyltransferase, rat is a biocatalyst that functions primarily by catalyzing the N-methylation of histamine. This enzyme plays a critical role in the metabolism of histamine, contributing to the regulation of physiological processes such as inflammatory responses and neurochemical signaling. Research applications include enzyme engineering aimed at optimizing reaction kinetics, enhancing substrate specificity, and improving enzyme stability under varying pH conditions, potentially facilitating dynamic control of enzymatic activity for various experimental needs.

3-Methylhistamine dihydrochloride is a methylated derivative of histamine that serves as a significant biomarker in the study of immune responses. This compound has been shown to be upregulated in vaccinated murine models, making it useful for research applications focused on immunological studies and histamine-related pathways. Its role in the modulation of immune activity positions it as a valuable reagent in exploring allergic reactions and other histamine-mediated processes.

Immepip dihydrobromide acts as a selective agonist for the H3 histamine receptor. It is known to attenuate cortical histamine release, thereby influencing neurotransmitter dynamics. This compound is applicable in the study of neurological disorders, providing insights into histaminergic system modulation and its potential therapeutic effects.

Asenapine impurity 1 is a recognized impurity of Asenapine, an atypical antipsychotic known for its antagonistic activity on serotonin, adrenoceptors, dopamine, and histamine receptors. With reported pKi values ranging from 8.2 to 10.5 across these targets, it is relevant for studies investigating the pharmacological profile of Asenapine. This impurity is important for quality control and characterization in research contexts focused on schizophrenia and bipolar disorder treatments.

N-Formyl desloratadine is an inhibitor targeting the H1 histamine receptor, primarily utilized as a biochemical assay reagent control. This compound demonstrates significant antihistamine activity, making it an essential tool for research related to allergic responses and histamine receptor activity. Its use in pharmacological studies allows for the assessment of H1 receptor modulation and the investigation of allergic conditions.

Desloratadine-d5 hydrochloride is a stable isotope-labeled derivative of Desloratadine hydrochloride, designed for use in quantitative mass spectrometry applications. This compound retains the pharmacological properties of the parent drug while providing a valuable tool for understanding drug metabolism and pharmacokinetics. It is particularly suitable for research in allergology and histamine receptor studies, facilitating the assessment of drug interactions and efficacy in various biological systems.

Famotidine is a competitive antagonist of the histamine H2-receptor, primarily involved in the inhibition of gastric acid secretion. This compound demonstrates significant biological activity in reducing gastric acidity, making it valuable in research related to acid-related gastrointestinal disorders. Famotidine can be utilized in studies investigating the pathophysiology of conditions such as peptic ulcers and gastroesophageal reflux disease (GERD).

Chlorcyclizine is a histamine H1 receptor antagonist that modulates allergic responses and reduces symptoms of histamine-mediated conditions. This compound exhibits effective anti-allergic properties, making it useful in studying the mechanisms of allergic reactions and potential therapeutic interventions. Research applications include the investigation of histamine-related pathways and the evaluation of antihistaminic effects in various biological systems.

Buclizine is an orally active antihistamine that targets histamine receptors, reducing allergic responses. In addition to its antiallergic properties, Buclizine has demonstrated teratogenic effects in rodent models and exhibits anti-tumor activity, making it of interest in cancer research. Its diverse mechanisms of action make it valuable for studies on histamine-related pathways and potential therapeutic applications in oncology.